T. Rowe Price Associates’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98K | Sell |
83,868
-3,806
| -4% | -$4.45K | ﹤0.01% | 2898 |
|
|
2025
Q1 | $119K | Sell |
87,674
-4,546,812
| -98% | -$6.17M | ﹤0.01% | 2781 |
|
|
2024
Q4 | $61M | Sell |
4,634,486
-200,327
| -4% | -$2.64M | 0.01% | 692 |
|
|
2024
Q3 | $54.2M | Buy |
4,834,813
+232,490
| +5% | +$2.61M | 0.01% | 736 |
|
|
2024
Q2 | $49.5M | Buy |
4,602,323
+643,235
| +16% | +$6.91M | 0.01% | 729 |
|
|
2024
Q1 | $59M | Buy |
3,959,088
+173,172
| +5% | +$2.58M | 0.01% | 684 |
|
|
2023
Q4 | $68.6M | Buy |
3,785,916
+434,429
| +13% | +$7.87M | 0.01% | 615 |
|
|
2023
Q3 | $58.1M | Buy |
3,351,487
+380,554
| +13% | +$6.6M | 0.01% | 638 |
|
|
2023
Q2 | $53.8M | Buy |
2,970,933
+864,689
| +41% | +$15.7M | 0.01% | 681 |
|
|
2023
Q1 | $56M | Buy |
2,106,244
+900,510
| +75% | +$24M | 0.01% | 655 |
|
|
2022
Q4 | $23.3M | Sell |
1,205,734
-26,110
| -2% | -$505K | ﹤0.01% | 869 |
|
|
2022
Q3 | $25.7M | Buy |
+1,231,844
| New | +$25.7M | ﹤0.01% | 831 |
|
|
2021
Q3 | – | Sell |
-210,678
| Closed | -$6.14M | – | 2969 |
|
|
2021
Q2 | $6.14M | Sell |
210,678
-3,479
| -2% | -$101K | ﹤0.01% | 1471 |
|
|
2021
Q1 | $8.42M | Buy |
+214,157
| New | +$8.42M | ﹤0.01% | 1416 |
|